Facebook Pixel Code
Haematology/Oncology
Haematology/Oncology

Sub-specialties of Paediatric Haematology/Oncology

The Sub-specialty Training Programs are for those already trained in General Paediatric Haematology/Oncology, who wish to obtain further clinical and/or research Sub-specialty Training. 

The academic year runs from July 1  to June 30. All trainees, irrespective of training program, are expected to start on July 1and all application requirements must be submitted well in advance of this start date.

NOTE: If you are applying to a Sub-specialty Paediatric Haematology/Oncology Training Program:

  • You CANNOT apply to a Core or Departmental Paediatric Haematology/Oncology Training Program
  • You are ONLY permitted to apply to a maximum of 2 Sub-specialty Programs

Language requirements:

Candidates that did not complete any part of their medical training in English are required to demonstrate proficiency in the English language. Candidates must successfully complete the foreign language requirement by the application deadline. This can be achieved by successfully completing one of the following language proficiency exams:

  • International English Language Testing System (IELTS) Academic Module: The minimum requirement is an overall band of 7.0, with no band below 7.0.
  • Test of English as a Foreign Language (TOEFL): The minimum score is a total score of 100 + 22 in the Writing module.

2021 Paediatric Haematology/Oncology Subspecialty Training Programs

Other Programs:

In addition, other customized programs may be developed according to the trainee’s interests and the divisional capacity. Such programs have previously included, but are not limited to, Sarcoma and Adolescent & Young Adult Oncology. Please send a letter of intent to education.haemonc@sickkids.ca if you would like to apply for a customized Sub-specialty Training Program. 

After successful completion, trainees will be presented a certificate from the University of Toronto, The Hospital for Sick Children, in the Sub-specialty of Paediatric Haematology/Oncology.  It is recommended, but not required, for applicants to have a source of external funding to support their salary throughout their training. Please see below for Sub-specialty Training Programs areas and eligibility.

 

General Haematology Fellowship

Program Description
 

The Paediatric Haematology Fellowship in the Division of Haematology/Oncology at The Hospital For Sick Children, Toronto, is a combined clinical and research fellowship which may be completed over one or two-years.  

The section of haematology provides care for the largest haematology population in the country, including approximately 1000 patients with sickle cell disease, 150 children with red blood cell membrane disorders such as hereditary spherocytosis, 100 patients with thalassemia and other red cell disorders requiring chronic transfusions, and 100 patients on chelation therapy. The hospital also follows approximately 1000 patients with various forms of vascular malformations and tumours, and a growing number of these patients are being placed on medical therapies and are followed by a multidisciplinary group of health care providers, including radiology, surgery, dermatology, hematology-oncology, ENT and neurosurgery. The section of Haematology is also home to one of the largest Paediatric Bone Marrow Failure and Myelodysplasia Programs in the world, which provides care for approximately 300 patients with acquired and inherited conditions. Trainees will have an opportunity to work with a high volume and range of complex patients with haemostatic and thrombotic disorders, representing the entire spectrum of bleeding and clotting diseases. Finally, there is opportunity for training experience in the Ontario Regional Haemoglobinopathy Laboratory in Hamilton, participation in blood transfusion camp and a two week placement in Canadian Blood Services, adult haematology/haemoglobinopathy rotations, being camp doctor at the Summer Sickle Cell Camp and involvement in the Sickle Cell Transition to Adult Care Program.  

The first year of training is primarily clinical, including two months each in general haematology, haemoglobinopathies, bone marrow failure and myelodysplasia, thrombosis and haemostasis, all in the out-patient and in-patient clinical settings. There is some flexibility to tailor the training program according to individual trainee needs. Laboratory activity related to these areas is encouraged and depends on individual trainee's past experiences, goals of learning, and future plans.   

The second year of training may either be a) primarily research focused (laboratory or clinically based research, focused on the study of paediatric blood disorders) or b) a combination of clinical work and research. In the first case (a), the trainee will work under the close supervision of a staff member of the haematology team. In the second case (b), the trainee may design a customized schedule to fulfill their clinical goals of learning, choosing from a variety of clinical rotations throughout the vast Toronto hospital network. This schedule will be finalized prior to the start of the year, in consultation with the haematology education team.   

For both streams outlined above, trainees are expected to contribute to clinical coverage. This includes attending, at the least, 1-2 continuity clinics (1-2 days per week) over 1-2 years, as well as participation in the on-call after-hours hematology coverage schedule. For all research projects, the trainee will be expected to present a research proposal, an interim report and a final report to the Division, with the goal of publication within 6 months of completion of fellowship training. 

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview  Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Haemoglobinopathies Fellowships

 

General Haemoglobinopathy Fellowship

Program Description

The Paediatric Haemoglobinopathy Fellowship in the Division of Haematology/Oncology at The Hospital For Sick Children, Toronto, is a combined clinical and research fellowship which may be completed over one or two-years. The hemoglobinopathy program cares for approximately 1000 patients with sickle cell disease, 100 patients with thalassemia , 100 patients on chelation therapy and other red cell disorders requiring chronic transfusions. There is opportunity for training experience in the Ontario Regional Haemoglobinopathy Laboratory in Hamilton, adult haematology/haemoglobinopathy rotations, being camp doctor at the Summer Sickle Cell Camp and involvement in the Sickle Cell Transition to Adult Care Program. 

The first year of training is primarily clinical focusing on the inpatient and outpatient management of the haemaglobinopathies. Laboratory activity related to these areas is encouraged and depends on the individual trainee's past experience, goals of learning and future plans.

The second year of training may either be a) primarily research focused (laboratory or clinically based research, focused on the study of paediatric blood disorders) or b) a combination of clinical work and research. In the first case (a), the trainee will work under the close supervision of a staff member of the haematology team. In the second case (b), the trainee may design a customized schedule to fulfill their clinical goals of learning, choosing from a variety of clinical rotations throughout the vast Toronto hospital network. This schedule will be finalized prior to the start of the year, in consultation with the haematology education team.

For both streams outlined above, trainees are expected to contribute to clinical coverage. This includes attending, at the least, 1-2 continuity clinics (1-2 days per week) over 1-2 years, as well as participation in the on-call after-hours hematology coverage schedule. For all research projects, the trainee will be expected to present a research proposal, an interim report and a final report to the Division, with the goal of publication within 6 months of completion of fellowship training. 

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application

Application Timeline

Application Opens

January 1st

Application Deadline

April 30th

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Dream Maker Inc. Fellowship in Sickle Cell Disease

Program Description

The Division of Haematology/Oncology at The Hospital for Sick Children, Toronto, in partnership with Dream Legacy Foundation and the Black Innovation Fellowship Program at Ryerson University, is pleased to present the Dream Maker Inc. Fellowship in Sickle Cell Disease.

Directed at Paediatricians in sub-Saharan Africa who have completed Paediatric Residency within the last 5 years and have demonstrated interest in patients with sickle cell disease (SCD), this will be an exciting 2-year fellowship based at The Hospital for Sick Children and in partnership with Toronto's Ryerson University.  The successful candidate will focus mainly on acquiring further clinical expertise in the care of patients with SCD in their 1st year of training. During their 2nd year of training, the candidate, in partnership with the Black Innovation Fellowship at Ryerson/DMZ, will have the opportunity to work closely with a start-up company that is interested in incubating new technology to help better diagnose, track, or care for people with SCD. This innovative technology will ideally be scalable across the candidate’s country in Africa and by extension the African continent.

The successful candidate will be expected to contribute to clinical coverage, comprising of attending SCD clinics over the 2 years, and participating in inpatient care of SCD patients and minimal after-hours call.

Eligibility

  • The applicant should have completed his/her Paediatric residency within the last 5 years
  • Applicants who have passed Part I of the National or Regional fellowship exams may be considered
  • The applicant should have demonstrated interest in and previous engagement with patients with SCD
  • Previous involvement with research projects or publications in SCD will be an advantage
  • Previous participation in other extraneous activities that may not be necessarily medical, but with potential to enhance the quality of life of patients with SCD
  • Ability to generate original ideas as evidenced by previous project execution. This need not be directly related to SCD
  • The applicant should be a citizen of an African country and working in Africa.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Thrombosis/Hemostasis Fellowships

 

General Thrombosis/Hemostasis Fellowship

Program Description

The Paediatric Haemostasis and Thrombosis Fellowship in the Division of Haematology/Oncology at The Hospital For Sick Children, Toronto, is a combined clinical and research fellowship that may be completed over one, two, or three-years. 

Training occurs at our internationally renowned centre, in the area of childhood bleeding and clotting disorders. The program was launched in 2001 due to the visionary work of Dr. Victor Blanchette and Dr. Maureen Andrew, changing the landscape of this area. Graduates of the program have gone on to successful academic and clinical careers in centres around the world.

For all candidates accepted into the program at The Hospital For Sick Children, the first year is primarily clinical. Training at a quaternary referral centre such as The Hospital For Sick Children ensures exposure to a high patient volume and high complexity level of care (i.e., > 650 open heart surgeries per year; 40-50 ECMO patients per year; 40-50 kidney transplants per year). Consequently, the entire spectrum of bleeding and clotting complications is represented. The rotations during the first year include 6 months in Thrombosis and Haemostasis in-patient and out-patient clinical services (including the paediatric comprehensive care hemophilia program), 1 month in the in-patient and out-patient paediatric stroke service, 2 months of laboratory training, and 3 months of elective rotations. 

The second and third year (optional) may either be a) primarily research focused (laboratory or clinical research focused on the study of Paediatric Thrombosis and Haemostasis) or b) a combination of clinical work and research. In both cases, the trainee will work under the direct supervision of a member of the thrombosis and haemostasis team for the development of the research proposal. In the second case b), the trainee may also design a customized schedule to fulfill their clinical goals of learning, choosing from a variety of clinical rotations throughout the vast Toronto hospital network. In both cases (a and b), trainees are encouraged to develop collaborative projects involving both SickKids and the original or future academic centre of the trainee.

The schedule of the fellowship will be outlined prior to the start of the year in consultation with the Medical Director of the Paediatric Haemostasis and Thrombosis Program. The final duration of the fellowship will be determined according to the needs and feasibility of conducting and developing the proposed research.

For both streams outlined above, trainees are expected to contribute to clinical coverage throughout their stay at The Hospital For Sick Children. This includes attending one of the continuity clinics (one day per week) over the entire fellowship duration, as well as participation in the on-call after-hours haematology coverage schedule. For all research projects, the trainee will be expected to present a research proposal, an interim report and a final report to the Haematology/Oncology Division, with the goal of publication within 6 months of completion of fellowship training. 

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Latin American Fellowship in Paediatric Hemostasis and Thrombosis

Program Description

This fellowship offered at The Hospital for Sick Children in the sub-specialty of Pediatric Hemostasis and Thrombosis is guided for early career staff or trainees from Latin America who wish to study and to specialize in the field of Pediatric Hemostasis and Thrombosis. The program aims to promote knowledge and expertise in clinical, coagulation laboratory methods, and to provide an introduction to clinical research in this field. The program will provide training for two years, which will both occur at The Hospital for Sick Children in Toronto, Ontario, Canada. 

The selected fellow will be awarded a salary to support training for two years. Funding will be provided according to the standard stipend offered to the department subspecialty fellows from the division of Hematology/ Oncology at The Hospital for Sick Children. 

Eligibility

  • Applicants must be a pediatric hematologist with less than five years of completion of clinical sub-specialty training or a Pediatric Hematology-Oncology trainee completing their Pediatric Hematology-Oncology training
  • Applicants must have a Brazilian citizenship
  • Applicants must be able to read, write and speak in English (TOEFL; CAMBRIDGE, CELPIP, IELTS; passing grade of acceptance to be dictated, as per the Post-graduate Medical Office [PMGE] from University of Toronto. For example, for IELTS, a minimum score of 7 is required in each section)
  • Applicants must not be employed by a pharmaceutical, biomedical, medical device, or any other for-profit company/organization
  • Applicants must provide a curriculum vitae (CV) in English encompassing their undergraduate, graduate and post-graduate education, including their previous clinical, laboratory and research experience in the field of Pediatric Thrombosis and Hemostasis. In addition, any ongoing projects including abstracts presented and/or accepted for presentation or publication should be listed. Presentations at local, provincial, national or international forums should also be numbered.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Bone Marrow Failure and Myelodysplasia Fellowship

Program Description
The Paediatric Bone Marrow Failure and Myelodysplasia Fellowship in the Division of Haematology/Oncology at The Hospital For Sick Children, Toronto, is a combined clinical and research fellowship which may be completed over one or two-years.

Training occurs in one of the largest Paediatric Bone Marrow Failure and Myelodysplasia Programs in the world, which cares for a population of approximately 300 patients with acquired and inherited conditions. Additionally, it is the home of the Canadian Inherited Bone Marrow Failure Registry (CIMFR) and the Canadian Aplastic Anemia and Myelodysplastic Syndrome Study (CAMS), both multi-centered studies focused on answering clinical and translational questions on inherited and acquired disease. There are two full-day out-patient clinics per week, weekly clinical and research team meetings, and an opportunity to attend a multitude of other teaching rounds. Approximately 50-70% of time is dedicated to basic, translational or clinical research under the supervision of highly engaged staff physicians. Clinical duties include outpatient and inpatient care, as well as participation in the on-call after-hours hematology coverage schedule.

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Bone Marrow Transplantation and Cellular Therapy (BMT-CT) Fellowship

Program Description

The Fellowship in Paediatric Bone Marrow Transplantation and Cellular Therapy is a one to two-year program aiming to train the next generation of leaders in the field of BMT and Cellular Therapy. The BMT-CT program performs over 100 pediatric transplants and cell therapies each year across the range of malignant and non-malignant indications, including treatments for thalassemia, sickle cell disease, inherited and acquired bone marrow failure, metabolic disorders, immunodeficiency/dysregulatory diseases, leukemia/lymphoma, and solid tumors. The experience, which can be tailored to individual needs, includes managing a busy inpatient service (3-5 months), a continuity clinic with longitudinal follow-up of a patient cohort, and a consult service with responsibility for transplant intake, donor and preparative regimen selection, apheresis and marrow harvests. Additional rotations include exposure to immunodeficiency patients, HLA typing and matching, transfusion medicine, laboratory experience with cell management, viral and chimerism monitoring, quality management, program development, transplant for adults with our partnership with Princess Margaret Hospital, and the long-term follow-up of patients.  The program is active in cellular therapies including CAR-T and gene therapy trials. There are tremendous research opportunities within the Hematology/Oncology Division, The Hospital For Sick Children and PGCRL Research Institute. Successful candidates will participate in on-call coverage on the in-patient BMT unit. For additional training beyond the one year, candidates are encouraged to apply to GFCC Research Fellowships.

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Permanent Residents or Canadian Citizens.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact:  
Education.haemonc@sickkids.ca

 

Back to top

 

Leukemia and Lymphoma Fellowship

Program Description

The Leukemia and Lymphoma (L/L) Fellowship in the Division of Haematology/Oncology at The Hospital For Sick Children, Toronto, is a one-year subspecialty training program with clinical and scholarly immersion related to the care of children with leukemia, lymphoma and histiocytic disorders. The Hospital For Sick Children sees approximately 25% of the children diagnosed with cancer in Canada and is a national referral centre for children with relapsed/refractory or otherwise very high-risk disease. Successful candidates will have the opportunity to lead section based inpatient rounds, be responsible for the diagnostic evaluation, treatment planning and disclosure for new patients, and participate in longitudinal ambulatory care. They will be involved in the New Agents and Innovative Therapy and the Cellular Therapy trial programs according to interest. Scholarly activity will be tailored to the candidate's research interest and expertise, and is a requirement of this fellowship program. The L/L trainee is responsible for coordination of the L/L Journal Club and the mentorship of junior trainees presenting at this venue. They are expected to take on a leadership role in weekly rounds and will have the opportunity to provide teaching in the formal Academic Half Day program. Successful candidates will be expected to provide on-call coverage, which is most commonly weekend daytime coverage on the in-patient haematology/oncology ward. Applicants are also encouraged to apply to the GFCC Research Fellowships. 

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Post-Doctoral board certified Paediatric Haematology/Oncology or Paediatric Haematology trainees focused on leukemia research are also invited to apply.
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
education.haemonc@sickkids.ca 

 

Back to top

 

Meagan's Walk Fellowship in Paediatric Neuro-Oncology

Program Description

The Fellowship in Paediatric Neuro-Oncology in the Division of Haematology/Oncology at The Hospital For Sick Children, Toronto, is completed over a one, two or three-year period. It is an academic clinical and/or research fellowship that will provide the successful candidate with an opportunity to train in one of the largest, most world-renowned paediatric brain tumour programs and affiliated paediatric brain tumour research centres in the world (www.sickkids.ca/Research/BTRC/). The combined clinical and research programs have a global reputation for state-of-the-art multi-disciplinary care of paediatric brain tumour patients, and excellence in clinical and research training. Trainees will have the option to pursue a strict 12-month clinical training program with opportunities to develop the clinical academic skills necessary to practice as an expert consultant in Paediatric Neuro-Oncology at the highest level and to pursue additional research training. The Paediatric Brain Tumour Program at The Hospital For Sick Children sees 100 primary diagnosis/year and consults directly or via e-communications for more than 200 patients worldwide. There are dedicated international twinning programs for clinical care and clinical research with centres in Jordan, Morocco, Pakistan, Latin America, Caribbean and others. Trainees are mentored to develop strong clinical academic skills through involvement in clinical trials, preparation of clinical manuscripts, involvement in focused clinical projects and attendance at international meetings. Trainees who have an interest in further clinical academic or translational/basic research training beyond the core 12-month clinical Neuro-oncology training as a Meagan’s Walk Fellow will have opportunities to be considered for research funding through the prestigious Garron Family Centre Research Fellowship in Pediatric Haematology/Oncology, and work with faculty investigators with research expertise in clinical or translational/basic science. Successful candidates will participate in on-call coverage, which is most commonly weekend daytime coverage on the in-patient haematology/oncology ward.

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Neuroblastoma

Program Description

The Neuroblastoma Fellowship in the Division of Haematology/Oncology at The Hospital For Sick Children, Toronto, may be completed over one or two-years. The goal of training is to provide the successful candidate with experiences in two or more of the following: (1) the outpatient neuroblastoma clinic program, (2) translational research (in one of a number of labs with neuroblastoma related projects), and (3) experimental therapies/protocol development and the MIBG program.

The fellowship and relative duration for each component may be personalized to the interests of the applicant. Our Neuroblastoma Program has approximately 25 new patients per year and additional local, national and international consultations, including patients with refractory neuroblastoma and genetic predisposition to neuroblastoma. Active neuroblastoma research projects include but are not limited to (1) tumor initiating cell/ cancer stem cells, (2) murine metastatic models, (3) drug screening, (4) neuroblastoma cell signaling and apoptosis, (5) genetic predisposition to neuroblastoma. Successful candidates will participate in on-call coverage, which is most commonly weekend daytime coverage on the in-patient haematology/oncology ward. Applicants are also encouraged to apply to the GFCC Research Fellowships. This fellowship may be combined with the New Agents and Innovative Therapies (NAIT) Fellowship depending on the interests of the successful candidate. 

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

New Agents and Innovative Therapies (NAIT) Fellowship

Program Description

The Fellowship in New Agents and Innovative Therapies (NAIT) in the Division of Haematology/Oncology at The Hospital For Sick Children, Toronto, may be completed in one or two-years, with the goal of providing the trainee with experiences in the outpatient experimental therapy/Phase 1 clinic program and in letter of intent (LOI)/protocol development for experimental therapies. There is also opportunity to participate in weekly molecular tumour board meetings and regular national teleconferences of the developmental therapeutics group. In addition, for those with an interest, translational research projects may be possible in several labs with expertise in pharmacology, biomarkers, or pre-clinical models for drug development.

Our Phase 1 Program sees an average of 20 to 25 patients per year and additional local, national and international consultations, including patients with relapsed or refractory leukemias/solid tumors/brain tumors. The Hospital For Sick Children has the largest Paediatric Oncology Developmental Therapeutics Program in Canada and participates in multiple industry sponsored and investigator-initiated trials, as well as those from academic consortia such as NANT (neuroblastoma), PNOC (neuro-oncology) and pedCITN (immunotherapy). An MIBG therapeutic facility opened at The Hospital For Sick Children in early 2014 and the hospital also has a very active Cellular Therapy program for cancers. 

The fellowship program and relative duration for each component may be personalized to the interests of the applicant. Successful candidates will participate in on-call coverage, which is most commonly weekend daytime coverage on the in-patient haematology/oncology ward. Applicants are also encouraged to apply to the GFCC Clinician-Scientist Fellowship. 

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology  Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Childhood Cancer Survivorship Fellowship

Program Description

The Fellowship in Childhood Cancer Survivorship in the Division of Haematology/ Oncology at The Hospital For Sick Children, Toronto, is completed over a one or two-year period and will provide an opportunity for the trainee to obtain expert knowledge in the late effects of treatment for childhood cancer. It will provide the trainee with exposure to survivors of childhood cancer during their childhood, adolescent and adult years. In addition to understanding the physical late effects of cancer treatment, it will also provide exposure to the neuropsychological, psychosocial and emotional sequelae of the disease and to the challenges of transition from pediatric to adult care. Trainees will attend clinics at both The Hospital For Sick Children and the Princess Margaret Cancer Centre – together, these constitute Canada’s largest program for childhood cancer survivors. Approximately 700 survivors are seen in clinic at The Hospital For Sick Children each year.

Clinical exposure will include:

  • Attendance at weekly After Care clinics for survivors of childhood cancer in pediatric and adult settings
  • Specialized clinics for survivors of brain tumors and hematopoietic stem cell transplantation
  • Opportunity for rotations with other services that care for specific sequelae of childhood cancer (e.g. endocrinology, pulmonary function lab, echocardiography lab, clinical and neuropsychology). 

The fellowship will also provide the opportunity for the trainee to gain experience in research around survivorship issues. Concurrent completion of a post-graduate degree (e.g. in clinical epidemiology or education) will be possible. Trainees will be able to develop projects ranging from basic science to clinical research by taking advantage of the numerous ongoing research initiatives in the Aftercare section, including the Childhood Cancer Survivor Study (CCSS), the Pediatric Oncology Group of Ontario (POGO) childhood cancer registry, the IMPACT cohort of survivors of AYA cancers, the Children’s Oncology Group’s (COG) Survivorship and Outcomes committee, and CIHR-funded grants investigating cardiac and vascular outcomes in survivors. Successful candidates will participate in on-call coverage, which is most commonly weekend daytime coverage on the in-patient haematology/oncology ward.

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Cancer Genetics Fellowship

Program Description


The two-year fellowship in Cancer Genetics is established in recognition of extant, emerging and anticipated advances in molecular medicine that add levels of complexity to the care of children with cancer. The ‘grey zone’ of transition from laboratory-based discovery research to translational clinical application has been blurred with the very rapid implementation of next generation sequencing (NGS) technology into medical decision-making models. As such, it is incumbent on us to rethink our traditional discipline-specific training methods to ensure that the current and next generation of practitioners are familiar with, expert in, and will adapt their practices to incorporate these exciting yet complex discoveries and technical tools. These can be encapsulated under the following six themes: 1) the rapid emergence of NGS platforms as new diagnostic tools in paediatric cancer; 2) recognition of the critical importance of the cancer genome, transcriptome and methylome in explaining cancer biology; 3) opportunities that NGS provide for more precise diagnosis and risk stratification of common and rare cancers; 4) incorporation of economically manageable NGS platforms into CLIA-certified molecular diagnostic labs; 5) the ability to identify new molecular targets in relapsed patients, metastatic and ‘hard to treat’ cancers and creation of novel clinical trial design to incorporate innovative therapies such as immunotherapy and molecular inhibitors that rely on an understanding of the molecular architecture of tumors; and 6) the recognition that heritable genetic factors may play a role in the etiology of at least 40% of childhood cancers, leading to challenges for genetic testing, counseling and interpretation and application of gene-based results.

The Cancer Genetics Fellowship consists of intensive training in hereditary cancer and genetics including the diagnosis and management of patients and families with a germline cancer predisposition. The trainee will develop unique expertise decision-making for genetic testing, management and surveillance for patients (particularly children) with a hereditary cancer syndrome.  The trainee will also receive teaching and training in epidemiology, genetic counselling, adult cancer genetics, precision oncology/medicine and medical ethics. The two-year curriculum is constructed as follows:

Year 1: Clinical (60%) + Research (30%) + Other (10%)
Year 2: Clinical (20%) + Research (70%) + Other (10%)

Please click here for the detailed curriculum structure

The objectives of the training include the development of:

1.  Skills in working with a team of genetic counselors, geneticists, paediatric/adult oncologists, diagnostic radiologists, site-specific clincial specialists (eg. Endocrinology, GI), bioinformaticians, psychologists and ethicists in field of cancer genetics
2.  Diagnostic and interpretive skills in a wide variety of hereditary cancer syndromes
3.  Ability to communicate results to medical genetics professionals, to other clinicians (e.g. oncologists), laboratory personnel, and directly to patients and their families and recognize the psychological implications of a genetic problem in the family;
4.  Skills in structuring appropriate differential diagnosis and planing an appropriate course of investigation with respect to a personal and family history of cancer, including out patient programs, appropriate utilization of paramedical personnel, medical record keeping and quality assurance;
5.  Skills in developing and implementing appropriate surveillance strategies for geneticall at-risk patients;
6.  Skills to interpret laboratory investigations that pertain to cancer predisposition
7.  Development of a research interest and scientific portfolio in hereditary cancer genetics

Clinical Duties
Two ½-day clinics/week (CG clinic is one full day/week). Hospital calls will be required.

Eligibility

  • Applicants should be certified or board-eligible in Paediatric Haematology/Oncology or Paediatric Haematology. 
  • Applicants may be Canadian or International.

Application requirements and platform

The Hospital For Sick Children Haematology/Oncology Training Application 

Application Timeline

Application Opens

January 1

Application Deadline

April 30

Application Review & Interview Period

May/June

Notification of Decision

August - September

 

Program Contact
Education.haemonc@sickkids.ca

 

Back to top

 

Garron Family Cancer Centre Fellowship Opportunities

There are two pathways by which funding may be obtained for Garron Family Cancer Centre (GFCC) fellowships:

1. Restracomp

This pathway is for all individuals applying for graduate student or postdoctoral fellowships; this includes Paediatric Haematology/Oncology trainees who have completed their clinical training and wish to pursue graduate studies. There is no clinical requirement with these positions. There are two categories when applying: “fellows with a license” and “fellows without a license”; the latter category includes PhD trainees. Restracomp applicants funded by the GFCC must be engaged in cancer-related research. 
 
Deadlines for applications are published on the Research Institute website. Restracomp competitions are only held once a year (usually in the spring), but it is recommended applicants apply up to one year prior to planned arrival. Applicants are vetted through a Research Institute-coordinated peer review process. 

Please refer to the Research Training Site for more information

2. GFCC Research Fellowship

The Garron Family Cancer Centre (GFCC) offers unique fellowship opportunities for clinical trainees, nurses, pharmacists, allied health trainees and basic science investigators engaged in cancer research. The GFCC, as part of The Hospital For Sick Children, is one of Canada's top ranked Paediatric Oncology Centres. The fellowship opportunities aim to provide training through direct participation in basic science or clinical investigation under the supervision of world leaders in oncology research and clinical care. The goal is to promote career development in the clinician/investigator and clinician/scientist tracks.

For more information on the GFCC Fellowship opportunities, visit the GFCC website or contact garronfamily.cancercentre@sickkids.ca.